ArticleNpj viruses2025
Characterization of A(H1N1)pdm09 influenza viruses isolated between 2016 and 2019.
Article in Npj viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evolutionary trajectory and co-infection dynamics of human influenza A(H1N1) virus (2000-2025): an integrated framework informed by expert-informed bibliometrics.Frontiers in microbiology · 2026Pooled it
- Updated A(H1N1)pdm09 influenza virus ferret infection model permits refined antiviral assessment using aerosol inhalation challenge.PLoS pathogens · 2026Article
- Genomic Characterization and Structural Insights Into the Evolution of Influenza A(H1N1)pdm09 in Northeast India From 2009 to 2024.Journal of medical virology · 2026Article
- Hydroxypropyl Cellulose Enhances Immune Responses to the Current Seasonal Influenza Vaccine in Mice.Microbiology and immunology · 2026Article
- Antiviral Surface Protection of Polyhedral Oligomeric Silsesquioxanes (POSS)-Appended Hybrid Surface Materials.International journal of biomaterials · 2026Article
- Genomic Surveillance and Phylogenetic Analysis of Influenza A(H1N1) pdm09 and A(H3N2) Viruses in Burkina Faso, 2024.Advances in virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The A(H1N1)pdm09 virus, which caused the 2009 influenza pandemic, has continued to circulate in humans for over a decade. Understanding its biological properties is crucial for effective surveillance, prevention, and control. Here, we characterized recently circulating A(H1N1)pdm09 viruses, focusing on strains isolated between 2016 and 2019. HA gene-based phylogenetic tree analysis revealed that post-pandemic A(H1N1)pdm09 virus strains circulating between 2016 and 2019 form two clusters: subclade 6B.1 and subclade 6B.1 A.5a. Growth kinetics of nine selected representative strains from these clusters showed that subclade 6B.1 viruses replicated well in human lung cells, whereas some subclade 6B.1 A.5a viruses replicated poorly. In vivo, all viruses from both subclades caused significantly less weight loss in infected mice compared to the prototypic pandemic strain A/California/04/2009 (Cal04/2009). Additionally, virus titers in the lungs of mice infected with most viruses from subclade 6B.1 or 6B.1 A.5a were significantly lower than those in mice infected with Cal04/2009. Furthermore, evolutionary analysis suggested multiple transitions to a less pathogenic phenotype, indicating an evolutionary trend towards attenuation. These results demonstrate that A(H1N1)pdm09 viruses isolated between 2016 and 2019 are attenuated in mice, although the mutations responsible for this attenuation require further investigation. Our findings emphasize the need for continued monitoring of A(H1N1)pdm09 viruses to understand their evolutionary dynamics and potential impact on public health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.